Holen Sie sich die Stockscreener-App
10.17
1.14%
0.08
Handel nachbörslich:
10.17
Schlusskurs vom Vortag:
$10.09
Offen:
$9.9
24-Stunden-Volumen:
572.41K
Relative Volume:
0.75
Marktkapitalisierung:
$1.24B
Einnahmen:
$58.49M
Nettoeinkommen (Verlust:
$-105.04M
KGV:
-7.8249
EPS:
-1.2997
Netto-Cashflow:
$-13.78M
1W Leistung:
+8.45%
1M Leistung:
+75.34%
6M Leistung:
+141.25%
1J Leistung:
+9.79%
1-Tages-Spanne:
$9.81
$10.40
1-Wochen-Bereich:
$9.315
$10.95
52-Wochen-Spanne:
$3.30
$10.95
Immatics N V Stock (IMTX) Company Profile
Vergleichen Sie IMTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
10.17 | 1.23B | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-05-28 | Eingeleitet | Deutsche Bank | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-31 | Eingeleitet | Mizuho | Buy |
| 2023-03-24 | Eingeleitet | Bryan Garnier | Buy |
| 2020-11-20 | Eingeleitet | BofA Securities | Buy |
| 2020-09-22 | Eingeleitet | Goldman | Buy |
| 2020-07-27 | Eingeleitet | SVB Leerink | Outperform |
| 2020-07-24 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Immatics N V Aktie (IMTX) Neueste Nachrichten
Is Immatics N.V. (4A3) stock vulnerable to rate hikesJuly 2025 Selloffs & Intraday High Probability Setup Alerts - newser.com
Can Immatics N.V. stock rebound after recent weaknessWeekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
How Immatics N.V. stock responds to policy changesMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Is a relief rally coming for Immatics N.V. holders2025 Volatility Report & Daily Oversold Bounce Ideas - newser.com
Published on: 2025-10-14 01:16:11 - newser.com
Using fundamentals and technicals on Immatics N.V.Quarterly Profit Report & Capital Efficiency Focused Strategies - newser.com
Can Immatics N.V. stock hit analyst price targetsMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com
Is Immatics N.V. stock a dividend growth opportunityWeekly Stock Report & High Accuracy Trade Alerts - newser.com
What analyst consensus says on Immatics N.V. stock2025 Market Outlook & Long Hold Capital Preservation Tips - newser.com
Immatics N.V. Equity Warrant stock trend forecastJuly 2025 Decliners & Weekly High Potential Stock Alerts - newser.com
Using RSI to spot recovery in Immatics N.V. Equity Warrant2025 Retail Activity & Low Drawdown Trading Techniques - newser.com
Is now a turning point for Immatics N.V.Market Movement Recap & Safe Entry Momentum Tips - newser.com
Predicting Immatics N.V. trend using moving averagesPortfolio Value Report & Weekly Momentum Picks - newser.com
Will Immatics N.V. rebound enough to break even2025 Short Interest & Accurate Buy Signal Notifications - newser.com
Will Immatics' (IMTX) New CFO Appointment Reshape Its Long-Term Growth and Transformation Strategy? - simplywall.st
What institutional flow reveals about Immatics N.V.Portfolio Value Summary & Short-Term Swing Trade Alerts - newser.com
Immatics (NASDAQ:IMTX) Reaches New 1-Year HighHere's What Happened - MarketBeat
Immatics: Multiple Clinical Catalysts In Q4'25 And 2026 (NASDAQ:IMTX) - Seeking Alpha
Why Immatics N.V. (4A3) stock is a must watch tickerEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com
How sentiment analysis helps forecast Immatics N.V. Equity WarrantEarnings Trend Report & Daily Market Momentum Tracking - newser.com
Immatics NV Hits Day High with 10.2% Surge Amid Strong Intraday Performance - Markets Mojo
Immatics NV Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo
Immatics NV Stock Analysis and ForecastMarket Volatility Update & You’ll Thank Yourself in 6 Months - earlytimes.in
Immatics N.V. stock trend forecast2025 Geopolitical Influence & Consistent Profit Trading Strategies - newser.com
Analyzing Immatics N.V. with risk reward ratio charts2025 Risk Factors & Trade Opportunity Analysis Reports - newser.com
Can technical indicators confirm Immatics N.V.’s reversalMarket Volume Report & Stock Timing and Entry Methods - newser.com
Immatics' (IMTX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Reversal indicators forming on Immatics N.V. Equity Warrant stockDollar Strength & Real-Time Volume Surge Alerts - newser.com
How supply shortages influence Immatics N.V. (4A3) stock2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com
Using Bollinger Bands to evaluate Immatics N.V. Equity WarrantOptions Play & Step-by-Step Trade Execution Guides - newser.com
Using R and stats models for Immatics N.V. forecastingOil Prices & Free Technical Pattern Based Buy Signals - newser.com
Is Immatics N.V. stock ready for a breakoutBuy Signal & Technical Pattern Based Signals - newser.com
Will Immatics N.V. Equity Warrant rebound enough to break evenTrend Reversal & Consistent Growth Stock Picks - newser.com
Custom watchlist performance reports with Immatics N.V.July 2025 Action & Risk Controlled Stock Alerts - newser.com
Published on: 2025-10-05 03:07:55 - newser.com
Will Immatics (IMTX) Gain Momentum as New CFO Brings Biopharma Commercialization Expertise? - simplywall.st
Earnings visualization tools for Immatics N.V.Weekly Trade Analysis & Daily Oversold Stock Bounce Ideas - newser.com
Historical volatility pattern of Immatics N.V. visualizedMarket Performance Recap & Low Drawdown Investment Ideas - newser.com
Published on: 2025-10-03 05:43:05 - newser.com
Finanzdaten der Immatics N V-Aktie (IMTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):